Budget 2027 gives health €29.1bn. So why aren’t Mounjaro and Wegovy funded for obesity?
Budget 2027 gives Irish health €29.1bn. We examine Mounjaro and Wegovy funding, obesity costs in Ireland, and the NCPE’s €5.23bn budget-impact estimate.
EXPLORE A LITTLE FURTHER
9 stories from the Compound journal.
Budget 2027 gives Irish health €29.1bn. We examine Mounjaro and Wegovy funding, obesity costs in Ireland, and the NCPE’s €5.23bn budget-impact estimate.
How long do you stay on Mounjaro or Wegovy in Ireland? HSE guidance, withdrawal-trial evidence, weight regain, reviews, cost and reasons treatment may change.
Retatrutide is not approved in Ireland in 2026. See its Phase 2/3 weight-loss results, safety, likely availability and how it compares with Mounjaro, Wegovy…
How to get Ozempic in Ireland in 2026: prescription rules, HSE coverage, weight-loss use, cost, Wegovy and Mounjaro alternatives, and safe access.
Compare advertised Irish Wegovy, Mounjaro and Ozempic prices, dose-related costs and HSE funding. Dated sources and practical budgeting examples.
What STEP 1, STEP 4 and SURMOUNT-4 show about stopping semaglutide or tirzepatide, with clear weight-regain figures and practical questions for follow-up care.
GLP-1 side effects explained using EMA information and trial evidence: common digestive symptoms, dehydration, urgent warning signs and reporting in Ireland.
GLP-1 medicines in Ireland: verified prescribing trends, Ozempic, Wegovy and Mounjaro, trial results, HSE funding and safety, with primary-source references.
Are Ozempic, Wegovy or Mounjaro covered by the medical card in Ireland in 2026? See HSE funding rules, DPS/LTI limits and when private payment applies.